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Introduction
Head and neck (H and N) cancers are among the most 
frequent tumors in the world with an estimated 686,328 
cases in 2012, comprising 300,373 cancers in the lip and 
oral cavity, 156,877 in the larynx, 142,387 in the other 
pharynx and 86,691 cancers in the nasopharynx. This type 
of cancer includes malignant tumors in the tongue, oral 
cavity, nasal cavity, pharynx, paranasal sinuses, larynx 
and salivary glands (World Health Organization, 2015). 
Among all H and N cancers, laryngeal cancer is the most 
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common type and accounts for 2.2% of cancers in men 
and 0.4% in women and is the second most common type 
of respiratory tract cancers after lung cancer. In 2018, 
there was an estimated 650,000 cases of H and N cancers 
world wide and 330,000 deaths happened from this cancer 
(Bray et al., 2018). 
In Iran, like other parts of the world, laryngeal cancer 
is among the most common types of H and N cancers. 
But, despite the fact that H and N cancers most commonly 
occur in high ages in other parts of the world, these 
cancers including laryngeal cancer, are common under 
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the age of 41 years in Iran (Larizadeh et al., 2014), this is 
probably due to different environmental exposures and risk 
factors in Iran (Emadzadeh et al., 2017). There is a wide 
geographical variation in the incidence of H and N cancers 
in different countries (Simard et al., 2014), which amounts 
to 5-50% variation across the world (Ajayi et al., 2007) . 
This variation may be due to differences in lifestyle, bad 
dietary habits, occupational exposures, vitamin deficiency, 
human papillomavirus (HPV) 16, and poor oral hygiene, 
although smoking and alcohol use are among the most 
common risk factors (Pezzuto et al., 2015). Some evidence 
shows that in some parts of the world, with decreased rates 
of smoking, these cancers have also decreased (Sturgis 
and Cinciripini, 2007). However, this decrease has not 
happened in other countries, which shows other important 
risk factors are involved as well (Blomberg et al., 2011).
On the other hand, the prevalence of alcohol 
consumption in some countries like Iran, is very low 
(Nasrollahzadeh et al., 2008; Naghibzadeh Tahami et al., 
2014; Naghibzadeh-Tahami et al., 2016; Lankarani et 
al., 2017) and studies conducted in Iran, were not able to 
show a significant relation between alcohol use and other 
types of cancers such as esophageal (Nasrollahzadeh et 
al., 2008), gastric, colorectal (Naghibzadeh-Tahami et al., 
2016; Lankarani et al., 2017), and bladder (Akbari et al., 
2015). Therefore, other risk factors should be investigated 
for these cancers in Iran.
Regular use of opium maybe a risk factor for 
some diseases, including cancer. Previous studies 
have shown a relation between O and D use and the 
risk of laryngeal (Mousavi et al., 2003; Bakhshaee et 
al., 2017), gastric (Shakeri et al., 2013; Naghibzadeh 
Tahami et al., 2014; Sadjadi et al., 2014), esophageal 
(Nasrollahzadeh et al., 2008; Shakeri et al., 2012), 
colorectal (Naghibzadeh-Tahami et al., 2016; Lankarani 
et al., 2017), pancreatic (Moossavi et al., 2017) and lung 
(Masjedi et al., 2013)cancer. 
It was estimated that about 0.3-0.5% (12-21 billion 
people) around the world, aged 15-64 years, had at least 
a history of O and D use, in 2009 (UNODC, 2011). 
In Iran, 20% of the population aged 15 - 60 has a history 
of drug abuse, and one in 17 is a regular user(Momtazi 
and Rawson, 2010). In Northern Iran, about 17% of the 
population aged 40 and over, has a history of O and D 
use (Pourshams et al., 2009), and this may be one of the 
causes of the high incidence of esophageal cancer in this 
area (Nasrollahzadeh et al., 2008).
According to various studies, the prevalence of 
OandD use in Kerman, a city in South-East Iran, has 
been estimated to be between 11% and 15% (Nakhaee 
et al., 2008; Najafipour et al., 2015). Recently, in a 
study conducted on hospital in-patients and their healthy 
companions in Kerman, the prevalence of self-reported 
opium use, was 36.5% in patients and 19.3% in healthy 
companions (Rashidian et al., 2017). Although, there are 
many hospital based studies conducted on the relation 
between O and D use and laryngeal cancer, but as far as 
we know no population base study has been performed 
to investigate the effect O and D use on H and N cancers. 
The aim of this case-control study was to investigate 
the relation between O and D use and HandN cancers in a 
population with a relatively high prevalence of opioids use. 
In this study, the relation between smoking and alcohol use 
and the risk of HandN cancers was investigated as well.
Materials and Methods
Sample
In this matched case-control study, 140 patients 
with HandN cancers (nasal cavity, paranasal sinuses, 
oral cavity, pharynx, larynx and salivary glands) whose 
pathologic information was registered in the Cancer 
Registry of Kerman University of Medical Sciences, from 
Jan 2014 to Dec 2017, were included. 
Sampling began by enrolling all diagnosed cases from 
2017 and then enrolling cases from previous years until 
the required number of cases was recruited. 
Patients’ information including their home address, 
telephone number and cancer type were extracted from 
their medical records. After a telephone call to the patients 
and their families, a specific date and time was set up 
for a face-to-face interview for collecting additional 
information. For each case, two controls were matched for 
age (±5) and gender from the neighbors. In a systematic 
method, the nearest and first neighbors on the right 
side of the case home who had the inclusion criteria and 
willingness to cooperate in the study were selected as the 
matched controls. If the control was not home or did not 
want to cooperate, the next neighbor was approached. 
Data Collection
Data were collected using a two-part questionnaire. The 
first part consists of demographic information including 
gender, age, education, and marital status. The second 
part of the questionnaire included information about the 
use of OandD, alcohol, smoking and diet. The validity 
and reliability of this questionnaire had been approved in 
a previous study (Abnet et al., 2004). To minimize bias, 
all interviews were conducted by a trained interviewer. 
In order to minimize the under-reporting of opium use 
especially in the control group, a trained interviewer 
explained the purpose of the study to the participants 
clearly and convinced them that their information would 
be kept confidential. In order to maximize the participation 
of participants, all interviews were conducted at their 
homes and in a comfortable and friendly environment. 
Participant were divided into different age groups. 
The type and amount of opium use was questioned. 
In order to quantify opium and cigarette use, their amount 
and duration of consumption were asked. The daily use of 
opium was measured based on the local measurement unit, 
Nokhod, which is equal to 0.2 gr. The type of opioids used 
was divided into four categories: raw opium (teriak), sap 
(shireh), burned opium (sukhteh) and heroin. In this study, 
the use of heroin or burned opium was not reported by 
any subjects; therefore, only raw opium and sap entered 
the final analysis. 
The diet of the participants was inquired through 
a questionnaire which included the dietary habits of 
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larynx and salivary glands), and laryngeal cancer. There 
were enough laryngeal cancers to do separate analysis.
In order to estimate the crude and adjusted odds ratio, 
conditional logistic regression with 95% confidence 
intervals were used. In all multivariate models, the 
confounding effect of only significant variables were 
evaluated in the univariate analysis. Moreover, only the 
variables with P-value less than 0.1 in the univariate 
analysis were added to the final multivariate models. The 
impact of opium exposure was calculated by adjusting 
the effects of other possible risk factors (cigarettes and 
alcohol). Multiplicative interactions between cigarette 
smoking (ever use) and opium use (ever use and 
cumulative dose) were evaluated using the likelihood ratio 
test. Statistical significant levels were considered P<0.05. 
All statistical analyses were performed using STATA 12.0 
(Stata Corp, College Station, TX, USA).  
Results
The estimated sample size for this study was174 
patients and 348 controls. However, thirty four out of 174 
patients did not participate in this study and the frequency 
of non-response was 19.5%. Therefore, 140 cases and 
280 controls were included in final analysis. Most cases 
(79.28%) had laryngeal cancer. Among the cases, the 
majority (75.0%) were male and 97.14% were married. 
Most of the cases (64.29%) were aged 61-70 years. More 
than half of the cases were illiterate or only had primary 
school education (55.71%). Controls were well matched 
for age, gender; and no significant difference was observed 
(P>0.05). Other demographic information about cases and 
Iranians, especially local foods. 
If the person was alive, the interviews were done 
face-to-face, otherwise, the closest family member would 
be interviewed. 
Ethics approval and consent to participate
The aims of the study was completely explained to the 
participants and it was ensured that all subjects were fully 
aware of the scope of our study and signed an informed 
consent form. In this regard, ethical principles on four 
main issues including harm to participants; deception; 
invasion of privacy or lack of informed consent were 
considered. This study was also approved by the ethics 
committee of Kerman University of Medical Sciences 
(KUMS) with ID code KNRC/95_19/EC.
Statistical analysis 
The cumulative consumption of each type of opioid, 
cigarette and alcohol was calculated as average daily 
use × duration of consumption, and participants were 
categorized into three groups; non-users, low users 
(≤ median use in the controls) and high users (>median 
use in the controls). The median use in the control group 
was considered as a criterion for classifying the population 
into high and low use groups. In all analyzes, the non-user 
group was considered as the reference group.
In this study, some people started opioid use after 
cancer diagnosis. In order to minimize reverse causality, 
only the history of O and D use at least 2 years before 
cancer diagnosis was considered. In the present study, 
cancers were divided into two groups; H and N cancers 
(nasal cavity, pharynx, paranasal sinuses, oral cavity, 
Variable All Head and Neck 
cancers †
Matched controls Laryngeal cancer † † Matched controls
N 140 280 111 222
Gender
     Male 105 (75.0) 210 (74.2) 95 (85.59) 190 (85.59)
     Female 35 (25.0) 70 (25. 0) 16 (14.41) 16 (14.41)
P-value 1.0 1.0
Marital status
     Married 136 (97.14) 267 (95.36) 109 (98.20) 215 (96.85)
     Single 4 (2.86) 13 (4.64) 2 (1.8) 7 (3.15)
P-value* 0.38 0.47
Age
     ≤ 50 35 (25.0) 69 (24.64) 24 (21.62) 48 (21.62)
     51-70 90 (64.29) 179 (63.93) 76 (68.47) 150 (67.57)
     > 70 15 (10.71) 32 (11.43) 11 (9.91) 24 (10.81)
P-value* 0.97 0.96
Education
     Illiterate and elementary 78 (55.72) 73 (26.07) 66 (59.46) 59 (26.58)
     Middle and high school 50 (35.72) 117 (41.79) 38 (34.23) 92 (41.44)
     High School Diploma and above 12 (8.58) 90 (32.14) 7 (6.31) 71 (31.98)
P-value* 0.001 0.001
Table 1. Demographic Variables of Case and Control Groups
† Includes nasal cavity, pharynx, paranasal sinuses, oral cavity, larynx, and salivary glands cancers. †† Includes only laryngeal cancer; *P value 
calculated using McNemar’s test.
Hosnyeh Alizadeh et al
Asian Pacific Journal of Cancer Prevention, Vol 21786
controls are presented in Table 1. The most common age 
for the onset of cigarette smoking (88.78) and opioids use 
(48.52%) was under 20 years and between 20-30 years. 
Fumigating was the most common method of use among 
cases (93.0%) and controls (100%). In total, 70.0% of 
cases and 26.79% of the controls had a history of opioids 
use (P<0.001).
Table 2 shows the results of opium, cigarette and 


















     Never 42 (30.00) 205 (73.21) Referent Referent 23 (20.72) 158 (71.17) Reference Reference
     Ever 98 (70.00) 75 (26.79) 11.82 (6.07- 23.0) 8.13 (4.08- 16.21) 88 (79.28) 64 (28.83) 17.52 (7.56- 40.60) 11.98 (5.05-28.39)
Amount of daily opium use
     Never used 42 (30.00) 205 (73.21) Referent Referent 23(20.72) 158 (71.17) Reference Reference
     ≤Median †† 45 (32.14) 43 (15.36) 9.42 (4.55- 19.47) 7.19 (3.32- 15.60) 41 (36.94) 36 (16.22) 14.67 (5.95-36.20) 11.17 (4.33- 28.83)
     >Median 53 (37.86) 32 (11.43) 15.30 (7.12- 32.93) 9.22 (4.19- 20.28) 47 (42.34) 28 (12.61)  21.07 (8.35-53.13) 12.82 (4.96- 33.11)
Duration
     Never used 42 (30.00) 205 (73.21) Referent Referent 23 (20.72) 158 (71.17) Reference Reference
     ≤Median 58 (41.43) 47 (16.79) 8.37 (4.43- 15.81) 5.65 (2.90- 10.98) 57 (51.35) 40 (18.02) 13.96 (6.23- 31.27) 7.05 (3.17- 15.67)
     >Median 40 (28.57) 28 (10.00) 19.09 (7.87-46.25) 13.16 (5.32-32.53) 31 (27.93) 24 (10.81) 19.79 (7.28- 53.78) 13.68 (5.12- 36.56)
Cumulative use of Opium†††
     Never used 42 (30.00) 205 (73.21) Referent Referent 23 (20.72) 158 (71.17) Reference Reference
     ≤Median†† 48 (34.29) 42 (15.00) 9.05 (4.60-18.05) 6.52 (3.18- 13.36) 44 (39.64) 35 (15.77) 13.23 (5.73-30.53) 9.46 (3.97- 22.52)
     >Median 50 (35.71) 33 (11.79) 14.07 (6.59-30.03) 8.91 (4.03- 19.65) 44 (39.64) 29 (13.06) 18.40 (7.54-44.90) 11.17 (4.44- 28.09)
Cigarette smoking
     Never 48 (34.29) 167 (59.64) Referent Referent 26 (23.42) 119 (53.60) Reference Reference
     Ever 92 (65.71) 113 (40.36) 4.90 (2.65- 9.04) 3.23 (1.69- 6.17) 85 (76.58) 103 (46.40) 6.28 (3.06-12.88) 4.14 (1.93- 8.87)
Amount of daily tobacco use
     Never used 48 (34.29) 167 (59.64) Referent Referent 26 (23.42) 119 (53.60) Reference Reference
     ≤Median †† 33 (23.57) 57 (20.36) 3.18 (1.58-6.39) 2.54 (1.34-6.26) 29 (26.13) 51 (22.97) 3.92 (1.74-8.81) 3.42 (1.56-6.67)
     >Median 59 (42.14) 56 (20.00) 7.41 (3.65-15.04) 4.41 (1.78-7.58) 56 (50.45) 52 (23.42) 9.20 (4.14-20.47) 5.41 (2. 24-13.22)
Duration
     Never used 48 (34.29) 167 (59.64) Referent Referent 26 (23.42) 119 (53.60) Reference Reference
     ≤Median †† 54 (38.57) 78 (27.86) 4.07 (2.14- 7.73) 2.90 (1.46- 5.73) 49 (44.14) 71 (31.98) 5.08 (2.40- 10.73) 3.58 (1.61- 7.94)
     >Median 38 (27.14) 35 (12.50) 7.46 (3.49- 2.39) 4.13 (1.83- 9.30) 36 (32.43) 32 (14.41) 9.98 (4.19-23.74) 5.76 (2.27- 14.59)
Cumulative use of cigarette smoking †††
     Never used 48 (34.29) 167 (59.64) Referent Referent 26 (23.42) 119 (53.60) Reference Reference
     ≤Median†† 37 (26.43) 57 (20.36) 3.65 (1.83- 7.27) 2.67 (1.29- 5.50) 33 (29.73) 51 (22.97) 4.61(2.07-10.27) 3.36 (1.44-7.81)
     > Median 55 (39.29) 56 (20.00) 6.59 (3.26-13.30) 4.06 (1.90- 8.67) 52 (46.85) 52 (23.42) 8.20 (3.71-18.13) 5.16 (2.19-12.16)
Alcohol use
     Never use 126 (90.00) 268 (95.71) Referent Referent 100 (90.09) 212 (95.50) Reference Reference
     Ever use 14 (10.00) 12 (4.29) 2.54 (1.12- 5.79) 4.26 (1.67- 10.84) 11 (9.91) 10 (4.50) 2.43 (0. 96 - 6.14) 5.00 (1.72-14.48)
Amount of daily Alcohol use
     Never used 126 (90.00) 268 (95.71) Referent Referent 100 (90.09) 212 (95.50) Reference Reference
     ≤Median†† 5 (3.57) 6 (2.14) 1.78 (0. 53- 5.89) 1.83 (0. 41-6.91) 4 (3.60) 6 (2.70) 1.50 (0. 38-5.84) 0.85 (0. 14-4.84)
     > Median 9 (6.43) 6 (2.14) 3.42 (1.13- 10.34) 7.36 (1. 38- 29.32) 7 (6.31) 4 (1.80) 3.57 (1. 04-12.24) 8.85 (2. 64-30.07)
Duration
     Never used 126 (90) 268 (95.71) Referent Referent 100 (95.50) 212 (95.50) Reference Reference
     ≤Median†† 5 (3.57) 6 (2.14) 1.89 (0. 56- 6.30) 1.62 (0. 50- 5.22) 3 (2.7) 5 (2.25) 1.42 (0. 33-6.14) 1.73 (0. 71-8.22)
     > Median 9 (6.43) 6 (2.14) 3.15 (1.11- 8.93) 6.56 (2. 47- 28.34) 8 (7.21) 5 (2.25) 3.29 (1.06-10.17) 7.36 (3.48-27.32)
Cumulative use of alcohol use †††
Never used 126 (90) 268 (95.71) Referent Referent 100 (90.09) 212 (95.50) Reference Reference
≤Median 5 (3.57) 7 (2.50) 1.62 (0. 50- 5.22) 1.93 (0. 51- 7.22) 3 (2.70) 6 (2.70) 1.19 (0. 29- 4.90) 1.84 (0. 37- 9.15)
> Median 9 (6.43) 5 (1.79) 3.74 (1.24- 11.25) 6.36 (2.38- 29.32) 8 (7.21) 4 (1.80) 4.06 (1.21-13.59) 7.19 (2. 79-32.87)
Table 2. The Association between the Use of Opioid and Its Derivatives, Cigarette, Alcohol and the Incidence of H 
and N Cancers
† Confounding effect of specific dietary factors such as the use of meat, fruit and vegetables, hydrogenated fats, olive oil as well as levels of 
education were controlled. †† Median of use in the control group was considered as a criterion. †††Cumulative use was obtained by multiplying the 
amount of use (per day) and the duration of use (per year).
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alcohol use. As shown in this Table, 70% of cases with 
HandN cancers and 26.79% of controls had a history of 
opioids use. 
Based on the results, O and D use is associated with 
an increased risk of H and N cancers (Adjusted OR: 8.13; 
CI: 4.08-16.21) and laryngeal cancer (Adjusted OR: 11.98; 
CI: 5.05-28.39).
The amount of daily use of opium increased the 
risk of H and N cancers (OR: 9.22; CI: 4.19-20.28), 
and laryngeal cancers (Adjusted OR: 12.82; CI: 
4.96-33.11). In addition, the duration of opium use, 
significantly increased the risk of all H and N cancers 
(Adjusted OR: 13.16; 95% CI: 5.32-32.5) and laryngeal 
cancer (Adjusted OR: 13.68; 95% CI: 5.12-36.56). 
There was a dose-response relationship between 
cumulative use of opium and the incidence of all H and 
N cancers (Adjusted OR: 8.91; 95% CI: 4.03-19.65). The 
dose-response relationship was also observed in laryngeal 
cancer (Adjusted OR: 11.17; 95% CI: 4.44-28.09).
About 65% of cases were smokers, while this rate was 
40% for controls. In univariate analysis, we observed a 
5-time increase in H and N cancer risk associated with 
smoking tobacco.(OR= 4.9; 95% CI: 2.65-9.04), but also 
multivariate analysis showed that after adjustment of diet 
and  education, the relationship was significant (Adjusted 
OR: 3.23; 95% CI: 1.69-6.17). The odds ratio was 
significant in laryngeal cancer (Adjusted OR: 4.14; 95% 
CI: 1.93-8.87) as well. The association was hold when 
we examined duration and intensity of tobacco smoking. 
Daily use of cigarettes had a significant relation with 
HandN cancers (Adjusted OR: 4.41; 95% CI: 1.78-7.58). 
Multivariate analysis also showed that the daily use 
of cigarettes was associated with an increased risk of 
laryngeal cancer (Adjusted OR: 5.41; 95% CI: 2.24-13.22). 
Similarly, the duration of cigarette smoking had a 
statistically significant association with the risk of H 
and N cancers (Adjusted OR: 4.13; 95% CI: 1.83-9.30) 
and laryngeal cancer (Adjusted OR: 5.76; 95% CI: 
2.27-14.59).
Multivariate analysis showed a significant association 
between the cumulative use of cigarettes and HandN 
cancers (OR: 4.06; 95% CI: 1.90-8.67) and laryngeal 
cancer (OR: 5.16; 95% CI: 2.19-12.16). 
The interaction between cigarette use (ever use) 
and opium use (ever or cumulative dose) was not 
statistically significant in HandN cancers (P=0.60 and 
0.76, respectively) or laryngeal cancers (P=0.13 and 0.35, 
respectively).
In H and N cancers, 10% of cases and 4.29% of 
controls had a history of alcohol use. In this group, 
the odds ratio was significant in multivariate analysis 
(Adjusted OR= 4.26; 95% CI: 1.67-10.84). Similarly, 
in the laryngeal cancer group, after adjustment 
for other confounding factors, alcohol use was 
associated with an increased risk of laryngeal cancer 
(Adjusted OR: 5.00; 95% CI: 1.72-14.48). 
Also, a significant relation was observed in multivariate 
analysis between daily alcohol use and HandN cancers 
(Adjusted OR: 7.36; 95% CI: 1.38- 29.32). Similarly, 
there was a significant association between daily alcohol 
use and laryngeal cancer (Adjusted OR: 8.85; 95% CI: 
2.64-30.07).
Also, after adjustment for confounders, duration of 
alcohol use was associated with HandN cancers (Adjusted 
OR: 6.56; 95% CI: 2. 47-28.34) and laryngeal cancer 
(Adjusted OR: 7.36; 95 % CI: 3.48-27.32). The cumulative 
use of alcohol, was associated with H and N cancers 
(Adjusted OR: 6.36; 95% CI: 2.38-29.32) and laryngeal 
cancers (Adjusted OR: 7.19; 95% CI: 2.79-32.87).
Discussion 
The present study is probably the first case-control 
study that showed a dose-response relation between opium 
use and HandN cancers, although the relation between 
opium use and laryngeal cancer has been investigated in 
previous studies (Mousavi et al., 2003; Bakhshaee et al., 
2017), in none of these studies, was the dose-response 
relationship evaluated.
The results of this study showed that the majority of 
the patients with H and N cancer had a history of opium 
use, and use of O and D may be associated with an 
increased risk of H and N cancers. Before causal inference, 
methodological problems should be considered. The 
association between opium use and an increased risk of 
cancers may be confounded by other risk factors such as 
age, gender, use of cigarette and alcohol (Naghibzadeh 
Tahami et al., 2014). Opium consumers are elderly people 
who are more likely to be cigarette smokers; however, 
in this study after adjustment for confounders, including 
cigarette smoking, alcohol use and diet, the results 
remained significant. 
Evidence provided by this study intensifies the 
existence of a causal relation between opium use and H 
and N cancers, as the relation observed in this study was 
relatively strong and opium use increased the risk of H 
and N cancers and laryngeal cancer over 12 and about 17 
times respectively. Other studies conducted in Iran have 
shown a relation between O and D use and laryngeal 
cancer as well. In a hospital-based study conducted in 
Kerman, opium use increased the risk of laryngeal cancer 
over 10 times (95% CI: 5.76–20.0) (Mousavi et al., 2003).
Another study conducted in Tehran, Iran, also showed 
that after controlling the effect of smoking, O and D use 
increased the risk of laryngeal cancer about 6 times (95% 
CI:1.10-33.23) (Bakhshaee et al., 2017). In a recent study, 
in Israel a significant relation was observed between IV 
(intravenous) O and D use and Supraglottic Squamous 
Cell Carcinoma and the odds ratio for patients with an 
IVDA history to have SG-SCC relative to G-SCC was 
10.84 (95% CI: 1.3-89.4) (Shoffel-Havakuk et al., 2017). 
Another study showed the odd ratio between opium use 
and the risk of oral cancers (tongue, palate, and buccal), 
to be 4.0 (95% CI: 1.2-13.6) (Razmpa et al., 2014). Also 
several studies showed that OandD use may increase 
the risk of cancers such as gastric (Shakeri et al., 2013; 
Naghibzadeh Tahami et al., 2014), esophageal (Hewer et 
al., 1978; Nasrollahzadeh et al., 2008; Shakeri et al., 2012), 
bladder (Akbari et al., 2015), lung(Masjedi et al., 2013), 
colorectal (Naghibzadeh-Tahami et al., 2016; Lankarani 
et al., 2017), and pancreatic (Moossavi et al., 2017).
Consistent with this study, a dose-response relationship 
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was observed in most of these studies (Nasrollahzadeh et 
al., 2008; Lambert et al., 2011; Naghibzadeh Tahami et 
al., 2014; Naghibzadeh-Tahami et al., 2016; Moossavi et 
al., 2017). However, some studies have not mentioned this 
relationship (Mousavi et al., 2003; Bakhshaee et al., 2017).
The consistency of the results in various studies may 
confirm the casual association reported in the present study 
and the carcinogenic effects of opium. Since opioids may 
be used to relieve cancer pain, in order to prevent reverse 
causality, the history of O and D use from at least 2 years 
before the date of cancer diagnosis was investigated and 
this represents the temporal relationship of association.
Many mechanisms have been proposed regarding the 
relation between opium use and the incidence of cancer. 
The use of opium and its alkaloids, including morphine 
may have mutagenic effects (Friesen et al., 1985). 
Empirical studies have shown that opium pyrolysis has 
mutagenic effects on Salmonella strains (Nasrollahzadeh 
et al., 2008). Also pyrolysis and alkaloids of morphine 
lead to sister chromatic exchange in human lymphocytes 
and morphological changes in cultured Syrian hamster 
embryo cells (Perry et al., 1983). These drugs have 
caused carcinogenic changes after being injected into 
tissues, under the skin, inside the trachea and into the 
gastrointestinal system of hamsters (Friesen et al., 1985). 
It has also been shown that pyrolysis and aromatic 
hydrocarbons (PAHs) released from burning opioid 
substances indirectly lead to DNA damage and, as a result, 
may stimulate mutagenic mechanisms (Nasrollahzadeh 
et al., 2008). In general, the carcinogenic mechanisms of 
opium have not been well identified and further studies 
are required to understand the carcinogenic mechanism 
of opium. H and N cancers are multifactorial and while 
opium is a rather prevalent and potent risk factor but it is 
possible that other factors (such as HPV) would have less 
prevalence in this population.
In addition, many impurities are added to opioids 
during their processing in Iran and these chemicals 
may have carcinogenic effects. One of these chemicals 
is lead, which is added in order to make it heavier 
so that drug dealers can make more profit. In studies 
conducted on addicted people in Kerman, the amount of 
lead in the blood of these people was higher than usual. 
The non-organic lead in these drugs can cause severe 
toxic and even carcinogenic effects (Hayatbakhsh et al., 
2017). The relation between occupational exposure to lead 
and gastric, lung and thyroid cancers have been shown in 
several studies (Wong and Harris, 2000). 
While smoking and alcohol use are two main risk 
factors for HandN cancers (Malhotra et al., 2017), in this 
study, the association between smoking and the incidence 
of H and N cancers was also statistically significant. In 
Iran, since almost all people are Muslims, the prevalence 
of alcohol use is much lower than in other parts of the 
world (Mozafarinia et al., 2017). 
Our study showed a relatively strong association 
between cigarette smoking and HandN and laryngeal 
cancers in univariate analysis which is consistent with 
many other studies in Iran and across the world (Jethwa 
and Khariwala, 2017; Smith et al., 2019). However, 
after adjustment for other confounding factors, cigarette 
smoking significantly increased the risk of H and N 
and laryngeal cancers. Although the results are similar 
to other countries across the world, but the strength of 
this relationship in Iran is weaker (Mousavi et al., 2003; 
Malhotra et al., 2017). The reason for these different 
results are not clear to us, although this could be due 
to some reasons such as the lower intensity or lower 
cumulative use of cigarettes in Iran or the different type 
of tobacco (Shakeri et al., 2013). Some other studies 
conducted in Iran showed no relation between smoking 
and esophagus (Nasrollahzadeh et al., 2008), colorectal 
(Naghibzadeh-Tahami et al., 2016; Lankarani et al., 2017), 
gastric (Shakeri et al., 2013; Naghibzadeh Tahami et al., 
2014) and bladder(Akbari et al., 2015)cancers. Also, 
two studies conducted in Linxian (China) and Golestan 
(Iran), which are areas with a high risk of esophageal 
cancer, showed a weak to moderate association between 
smoking and esophageal cancer, and authors concluded 
that smoking was not a strong risk factor for esophageal 
cancer in these specific populations (Tran et al., 2005). 
This might indicate that there are other stronger risk factors 
for H and N cancers and one might be opium.
Opioids use has a high prevalence in some parts of 
Iran. A study conducted in Golestan province showed that 
17% of adults had a history of opioids use (Sadjadi et al., 
2014), and based on current evidence, Kerman province 
is considered as one of the areas with a relatively high 
prevalence of opium use (Nakhaee et al., 2008; Najafipour 
et al., 2015; Rashidian et al., 2017). Based on this 
information and the existence of a strong relation between 
opium use and cancers, as well as high use of opium in 
some areas, a significant proportion of the burden of these 
cancers may be related to opioids use. It is estimated that 
there are about 15 million opioids consumers in the world 
(Shakeri et al., 2013), which is a great concern. 
Study strengths and limitations
This study had some limitations. One of the limitations 
was its low sample size, therefore different HandN 
cancers could not be analyzed separately. In addition, this 
study like other case-control studies was prone to recall 
bias, interviewer, and reporting bias. Under-reporting of 
opium use, especially in controls, was another possible 
bias, although by standardizing the interview process and 
employing a trained interviewer to conduct all interviews, 
the possible effect of this bias was minimized. Another 
limitation of this study is the wide confidence interval that 
may be due to the low sample size.
The most important strength of this study was that all 
cancer cases included had been confirmed pathologically, 
which minimized the probability of misclassification bias. 
Another strength of this study was using population-based 
neighbor controls rather than hospital controls which led to 
better control over socio-economic factors (Shakeri et al., 
2012). This study used a questionnaire which its validity 
and reliability have been proven in similar previous studies 
(Abnet et al., 2004).
Moreover further studies, such as prospective studies, 
may be helpful in further proving this casual relation, 
although it seems worthwhile to state that most studies on 
the association between opium and cancer are from Iran.
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Opium Use and Head and Neck Cancers 
In conclusion, this study showed that O and D use 
may be a risk factor for H and N cancers, including 
laryngeal cancer in Iran. There was a dose-response 
association. There was another dose-response relation that 
was related to cigarette smoking, however, there was no 
multiplicative interaction between cigarette smoking and 
opium use. On the other hand, due to the low sample size, 
the results should be interpreted with caution. The results 
are consistent with previous literature showing that opium 
is related to cancer.
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